as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High

0.63%
Downside
6.92%
Upside

52 Week's Low
52 Week's High

37.76%
Downside
220.75%
Upside

Check Macrogenics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$100.8M
EPS (TTM)
-1.71
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.21%
PE Ratio (TTM)
-1.6
Industry PE ratio
-0.8126129032258065
PEG Ratio
0.01
EBITDA
-70.5M
Revenue (TTM)
165.5M
Profit Margin
-21.99%
Return On Equity TTM
-69.71%
Track how Macrogenics, Inc. P/E has moved over time to understand its valuation trends.
Macrogenics, Inc. in the last 5 years
Lowest (-12.96x)
June 30, 2021
Today (-1.60x)
October 31, 2025
Industry (-0.81x)
October 31, 2025
Highest (-0.79x)
September 30, 2025
Today’s Price to Earnings Ratio: -1.60x
Compare market cap, revenue, PE, and other key metrics of Macrogenics, Inc. with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $100.8M | -91.78% | -1.6 | -21.99% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| NA | $36.1B | NA | NA | -3.89% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Macrogenics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Macrogenics, Inc. investment value today
Current value as on today
₹49,109
Returns
Returns from Macrogenics, Inc. Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Macrogenics, Inc.. Average target price of $3.75
Get share price movements and forecasts by analysts on Macrogenics, Inc..
What analysts predicted
57.6%UPSIDE
Target Price
$3.75
Current Price
$1.59
Analyzed by
18 Analysts
Target
$3.75
Macrogenics, Inc. target price $3.75, a slight upside of 57.6% compared to current price of $1.59. According to 18 analysts rating.
Search interest for Macrogenics, Inc. Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 13.19M → 22.24M (in $), with an average increase of 40.7% per quarter
 POSITIVE IMPACT
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, -41.03M → -36.25M (in $), with an average increase of 13.2% per quarter
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.6% return, outperforming this stock by 134.4%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.4% return, outperforming this stock by 199.4%
 NEGATIVE IMPACT
NEGATIVE IMPACTPrice Dip

In the last 7 days, MGNX stock has moved down by -8.2%
| Organisation | Macrogenics, Inc. | 
| Headquarters | 9704 Medical Center Drive, Rockville, MD, United States, 20850 | 
| Industry | Health Technology | 
| CEO | Mr. Eric Blasius Risser | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Mr. James Karrels | Senior VP, CFO & Corporate Secretary | 
| Dr. Stephen L. Eck M.D., Ph.D. | Senior VP of Clinical Development & Chief Medical Officer | 
| Dr. Ezio Bonvini M.D. | Senior VP of Research & Chief Scientific Officer | 
| Mr. Jeffrey Stuart Peters J.D. | Senior VP, General Counsel & Corporate Compliance Officer | 
| Mr. Steve Harig | Senior Vice President of Human Resources | 
| Ms. Beth Smith | VP, Controller & Treasurer | 
| Mr. Eric Blasius Risser | CEO, President & Director | 
| Dr. Thomas M. Spitznagel Ph.D. | Senior Vice President of Technical Operations | 
| Mr. Harish Krishnaswamy | Senior Vice President of Business Development & Portfolio Planning | 
Macrogenics, Inc. share price today is $1.59 as on at the close of the market. Macrogenics, Inc. share today touched a day high of $1.7 and a low of $1.58.
Macrogenics, Inc. share touched a 52 week high of $5.1 on and a 52 week low of $0.99 on . Macrogenics, Inc. stock price today i.e. is closed at $1.59,which is 68.82% down from its 52 week high and 60.66% up from its 52 week low.
Macrogenics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Macrogenics, Inc. (MGNX) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.86 in Macrogenics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Macrogenics, Inc. share’s latest price of $1.59 as on October 31, 2025 at 1:29 am IST, you will get 6.2893 shares of Macrogenics, Inc.. Learn more about
          
            fractional shares .
        
Macrogenics, Inc. stock has given -91.78% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?